PreciControl HBeAg quant - Hepatitis B virus e-antigen IVD, control - ARTG 440890

Access comprehensive regulatory information for PreciControl HBeAg quant - Hepatitis B virus e-antigen IVD, control in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 440890 and sponsored by Roche Diagnostics Australia Pty Limited, manufactured by Roche Diagnostics GmbH in Germany. The device registration started on February 13, 2024.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.